NCT04952246 is a clinical trial in Clinical Isolation Syndrome of Spinal Cord, sponsored by Peking University Third Hospital.

Who is sponsoring NCT04952246?

NCT04952246 is sponsored by Peking University Third Hospital.

What condition does NCT04952246 study?

NCT04952246 studies Clinical Isolation Syndrome of Spinal Cord, Multiple Sclerosis.

Is NCT04952246 still recruiting?

NCT04952246 is currently status unknown. Last updated 7 July 2021.

Last reviewed 2021-07-07 · How we verify

NCT04952246

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Isolation Syndrome of Spinal Cord and Multiple Sclerosis

Status unknown Last updated 7 July 2021

What this trial tests

trial in Clinical Isolation Syndrome of Spinal Cord in 150 participants. Status unknown.

Timeline

1 January 2010

Primary endpoint
30 November 2020

30 November 2023

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 January 2010
Primary completion	30 November 2020
Estimated completion	30 November 2023
Sites	1 location across China

Conditions studied

Clinical Isolation Syndrome of Spinal Cord — all drugs for Clinical Isolation Syndrome of Spinal Cord →
Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Peking University Third Hospital

Who can join

Eligibility, any sex, with Clinical Isolation Syndrome of Spinal Cord or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to investigate the factors that influence the progression of patients with clinically isolated spinal cord syndrome to multiple sclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04952246 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 7 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04952246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing